Surgical Oncology
Volume 21, Issue 1 , Pages 1-5 , March 2012

Peritoneal pseudomyxoma arising from the urachus

  • Alejandra Martínez

      Affiliations

    • Institut Claudius Regaud (ICR), Surgery, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 650493489; fax: +33 561424117.
    • ,
  • Gwénael Ferron

      Affiliations

    • Institut Claudius Regaud (ICR), Surgery, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Eliane Mery

      Affiliations

    • Institut Claudius Regaud (ICR), Pathology, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Laurance Gladieff

      Affiliations

    • Institut Claudius Regaud (ICR), Medical Oncology, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Jean Pierre Delord

      Affiliations

    • Institut Claudius Regaud (ICR), Medical Oncology, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Denis Querleu

      Affiliations

    • Institut Claudius Regaud (ICR), Surgery, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France

,Accepted 29 December 2009.

References 

  1. Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev. 2003;22:465–472
  2. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12:585–603
  3. Smeenk RM, Bex A, Verwaal VJ, Horenblas S, Zoetmulder FA. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications. J Surg Oncol. 2006;93:20–23
  4. Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994;219:109–111
  5. de Bree E, Witkamp A, Van DV, Zoetmulder F. Unusual origins of Pseudomyxoma peritonei. J Surg Oncol. 2000;75:270–274
  6. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42
  7. Ferron G, Dattez S, Gladieff L, Delord JP, Pierre S, Lafont T, et al. Pharmacokinetics of heated intraperitoneal oxaliplatin. Cancer Chemother Pharmacol. 2008;62:679–683
  8. Galati V, Donovan B, Ramji F, Campbell J, Kropp BP, Frimberger D. Management of urachal remnants in early childhood. J Urol. 2008;180:1824–1826
  9. Soto Delgado M, Pedrero Marquez G, Varo Solis C, Rodriguez-Rubio Cortadellas FO, Sanchez Bernal C, Gonzalez Moreno D. [Mucinous adenocarcinoma of the urachus and peritoneal pseudomyxoma], Actas Urol Esp. 2006;30:222–226
  10. Pinthus JH, Haddad R, Trachtenberg J, Holowaty E, Bowler J, Herzenberg AM, et al. Population based survival data on urachal tumors. J Urol. 2006;175:2042–2047
  11. Henly DR, Farrow GM, Zincke H. Urachal cancer: role of conservative surgery. Urology. 1993;42:635–639
  12. Herr HW, Bochner BH, Sharp D, Dalbagni G, Reuter VE. Urachal carcinoma: contemporary surgical outcomes. J Urol. 2007;178:74–78
  13. Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, et al. Multimodality management of urachal carcinoma: the M.D. Anderson Cancer Center experience. J Urol. 2003;169:1295–1298
  14. Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006;107:712–720
  15. Siefker-Radtke A. Systemic chemotherapy options for metastatic bladder cancer. Expert Rev Anticancer Ther. 2006;6:877–885
  16. Herr HW, Bochner BH, Sharp D, Dalbagni G, Reuter VE. Urachal carcinoma: contemporary surgical outcomes. J Urol. 2007;178:74–78
  17. Tsiouris A, Ahmed HU, Kumar N, Kaisary AV. Urachal tumour: clinical and radiological features of a poorly understood carcinoma. Ann R Coll Surg Engl. 2007;89:W17–W18
  18. Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol. 1997;16:1–9
  19. Loggie BW, Fleming RA, Hosseinian AA. Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. Urology. 1997;50:446–448
  20. Mendeloff J, McSwain NE. Pseudomyxoma peritonei due to mucinous adenocarcinoma of the urachus. South Med J. 1971;64:497–498
  21. Mizuno S, Furuta K, Kiyozawa R, Miki T, Jimi M, Ishikawa H, et al. [A case of pseudomyxoma peritonei in which the primary site is supposed to be the urachus], Nippon Shokakibyo Gakkai Zasshi. 1985;82:2979–2982
  22. Sasano H, Shizawa S, Nagura H, Yamaki T. Mucinous adenocarcinoma arising in a giant urachal cyst associated with pseudomyxoma peritonei and stromal osseous metaplasia. Pathol Int. 1997;47:502–505
  23. Shinohara T, Misawa K, Sano H, Okawa Y, Takada A. Pseudomyxoma peritonei due to mucinous cystadenocarcinoma in situ of the urachus presenting as an inguinal hernia. Int J Clin Oncol. 2006;11:416–419
  24. Stenhouse G, McRae D, Pollock AM. Urachal adenocarcinoma in situ with pseudomyxoma peritonei: a case report. J Clin Pathol. 2003;56:152–153
  25. Sugarbaker PH, Verghese M, Yan TD, Brun E. Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei. Tumori. 2008;94:732–736
  26. Takeuchi M, Matsuzaki K, Yoshida S, Nishitani H, Uehara H. Imaging findings of urachal mucinous cystadenocarcinoma associated with pseudomyxoma peritonei. Acta Radiol. 2004;45:348–350
  27. Yanagisawa S, Fujinaga Y, Kadoya M. Urachal mucinous cystadenocarcinoma with a cystic ovarian metastasis. AJR Am J Roentgenol. 2003;180:1183–1184
  28. Khalid K, Ahmed MS, Malik MS. Adenocarcinoma of urachal cyst associated with pseudomyxoma peritonei masquerading as abdominal tuberculosis: a case report and review of literature. Indian J Urol. 2008;24:258–260
  29. Sugiyama K, Ito N. Mucinous cystadenocarcinoma of the urachus associated with pseudomyxoma peritonei with emphasis on MR findings. Magn Reson Med Sci. 2009;8:85–89
  30. Yan TD, Padang R, Morris DL. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg. 2006;202:100–111
  31. Fernandez RN, Daly JM. Pseudomyxoma peritonei. Arch Surg. 1980;115:409–414
  32. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg. 1994;219:112–119
  33. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Lancet Oncol. 2006;7:69–76
  34. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727–731
  35. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MS, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241:300–308
  36. Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;27:239–243
  37. Butterworth SA, Panton ON, Klaassen DJ, Shah AM, McGregor GI. Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei. Am J Surg. 2002;183:529–532
  38. Elias D, Laurent S, Antoun S, Duvillard P, Ducreux M, Pocard M, et al. [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy], Gastroenterol Clin Biol. 2003;27:407–412
  39. Guner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis. 2005;20:155–160
  40. Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum. 2005;48:1372–1379
  41. Smeenk RM, Verwaal VJ, Zoetmulder FA. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei–a report of 103 procedures. Eur J Surg Oncol. 2006;32:186–190
  42. Scuderi S, Costamagna D, Vaira M, Barone R, De Simone M. [Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy], Tumori. 2003;89:43–45
  43. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol. 2004;11:393–398
  44. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98:277–282
  45. Sugarbaker PH. Are there curative options to peritoneal carcinomatosis?. Ann Surg. 2005;242:748–750
  46. Elias D, Glehen O, Gilly F. Monographie de l'AFC. France: Arnette, Wolters Kluwer; 2008;
    Ref Type: Generic.
  1. Faulkner JW, Greene LF, McDonald JR. Mucinous adenocarcinoma in a urachal cyst producing pseudomyxoma peritonaei. J Urol. 1954;72:217–221
  2. Gonzalez-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91:304–311
  3. Glehen O, Cotte E, Brigand C, Arvieux C, Sayag-Beaujard AC, Gilly FN. [Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: cytoreductive surgery and intraperitoneal chemotherapy], Rev Med Interne. 2006;27:382–391
  4. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104–109
  5. Stewart JH, Shen P, Russell GB, Bradley RF, Hundley JC, Loggie BL, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006;13:624–634
  6. Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg. 2006;93:1270–1276

PII: S0960-7404(10)00002-2

doi: 10.1016/j.suronc.2009.12.004

Surgical Oncology
Volume 21, Issue 1 , Pages 1-5 , March 2012

Article Tools

* Image Usage & Resolution